Y. Li et al. / Phytochemistry Letters 14 (2015) 239–244
243
lines than 7, which has the trans configuration. In addition, in
another pair of isomers, compound 3 (cis) showed stronger activity
than 9 (trans) against all of the tested cell lines, which suggested
that the cis configuration may increase activity. Compounds 6, 8
and 10 showed moderate cytotoxic potency, and 5, 7, and 11 were
tR = 36.3 min). Fr.C-4 was further subjected to pre-HPLC to give
compound 11 (48.0 mg, 65:35, tR = 24.4 min). Fr.D (45 g) was eluted
with CHCl2, CHCl2–MeOH (99:1, 98:2, 95:5, 93:7, 90:10, 85:15,
80:20, and 100:0, each 1.5 L), resulting in 11 subfractions (Fr.D1–Fr.
D11). Compounds 2 (15.0 mg, tR = 10.9 min), 7 (46.0 mg, tR = 21.6
min) and 8 (62.0 mg, tR = 28.9 min) were obtained from Fr.D-
2 using ODS CC and pre-HPLC (MeOH:H2O = 75:25, 7 mL/min,
210 nm).
inactive in some cell lines (IC50 > 20
mg/ml).
3. Experimental
3.1. General
3.4. Structural elucidation of compounds 1–5
3.4.1. Hemslepenside B (1)
IR spectra were measured using a Thermo Nicolet NEXUS-
670 FTIR spectrometer. Optical rotations were run on a JASCO P-
2000 polarimeter. HR-ESI-MS was determined using Thermo
Scientific Accela PDA and LTQ-Orbitrap XL mass spectrometers
(Thermo Fisher Scientific, Germany). NMR spectra were performed
on a Bruker Avance III HD NMR spectrometer (Bruker BioSpin).
White amorphous powder; [a D
(KBr) nmax 3423, 2947, 2705, 1684, 1637, 1458, 1382, 1251, 1167,
]
25: +28.15 (c = 0.1, MeOH); IR
1074 and 1033 cmꢀ1 1H NMR data see Table 1; 13C NMR data see
;
Table 2; and ESI-HRMS m/z 636.4474 ([M + NH4]+) (calcd for
C36H58O8NH4, 636.4475).
Preparative HPLC was run on
a LC-6AD Shimadzu Liquid
chromatograph equipped with an SPD-20A UV/VIS Detector and
3.4.2. Hemslepenside C (2)
an ODS column (YMC-Pack ODS-A column, 250 mm ꢁ 20 mm,
White amorphous powder; [a]D
25: +44.37 (c = 0.1, MeOH); IR
5
m
m). Column chromatography (CC) was performed using silica
(KBr) nmax 3383, 2930, 1629, 1466, 1381, 1168, 1075, 1010 and
943 cmꢀ1; 1H data see Table 1; 13C NMR data see Table 2; and ESI-
HRMS m/z 638.4630 ([M + NH4]+) (calcd for C36H60O8 NH4,
638.4632).
gel (300–400 mesh, Qingdao Marine Chemistry Ltd., China), an
ODS C18 (50 m, YMC Co., Ltd., Kyoto, Japan).
m
3.2. Plant material
3.4.3. Hemslepenside D (3)
Rhizomes of H. jinfushanensis were collected from Chongqing in
the People’s Republic of China in September 2012 and identified by
Dr. Si-rong Yi from the Chongqing Institute of Pharmaceutical
Plants. A voucher specimen (voucher number: HA201209B) was
deposited in the Institute of Materia Medica at the Shandong
Academy of Medical Science in China.
White amorphous powder; [a]
25: +44.53 (c = 0.1, MeOH); IR
D
(KBr) nmax 3406, 2963, 2882, 1691, 1462, 1384, 1167, 1074 and
1015 cmꢀ1; 1H data see Table 1; 13C NMR data see Table 2; and ESI-
HRMS m/z 636.4476 ([M + NH4]+) (calcd for C36H58O8 NH4,
636.4475).
3.4.4. 16,25-O-Diacetyl-cucurbitane F (4)
3.3. Extraction and isolation
White amorphous powder; [
(KBr) nmax 3450, 2976, 2930, 1738, 1692, 1631, 1431, 1371, 1248,
1058 and 1024 cmꢀ1 1H data see Table 1; 13C NMR data see
Table 2; and ESI-HRMS m/z 620.3796 ([M + NH4]+) (calcd for
34H49O9 NH4, 620.3799).
a]
25: +11.38 (c = 0.1, MeOH); IR
D
Air-dried rhizomes (3.0 kg) of H. jinfushanensis were cut into
slices, minced, extracted exhaustively with 95% EtOH under reflux
(3 ꢁ10 L) and filtered. The extract was concentrated to dryness in a
vacuum using a rotatory evaporator, concentrated to an aqueous
suspension and further extracted successively with EtOAc, CHCl3
and n-BuOH. The EtOAc fraction (200 g) was absorbed on 300 g of
silica gel (200–300 mesh) and chromatographed over a silica gel
(10 ꢁ120 cm, 2 kg) column using a gradient system of CHCl2 (8 L),
CHCl2–MeOH (99:1/8 L, 98:2/10 L, 95:5/12 L, 93:7/10 L, 90:10/12 L,
85:15/8 L, 80:20/6 L, and 100:0/5 L) to give five fractions (Fr.A–Fr.E).
Fr.A (25 g) was separated by a silica gel (300–400 mesh) and eluted
with a gradient system of CHCl2–MeOH (99:1, 98:2, 95:5, 93:7,
90:10, 85:15, 80:20, and 100:0, each 800 mL), resulting in six
fractions (Fr.A1–Fr.A6). Fr.A-2 (6.8 g) was absorbed on silica gel
(10 g) and eluted with CHCl2–MeOH (99:1, 98:2, 95:5, 93:7, 90:10,
85:15, 80:20, and 100:0, each 500 mL) to afford five subfractions
(Fr.A-2-1 to Fr.A-2-5). Subfraction A-2-4 (900 mg) was purified via
pre-HPLC (MeOH:H2O = 65:35, 7 mL/min, 210 nm) to give com-
pounds 4 (30 mg, tR = 35.7 min), 6 (21 mg, tR = 40.2 min) and 10
(15 mg, tR = 44.9 min). Fr.B (15.3 g) was absorbed on 20 g of silica gel
and chromatographed with CHCl2–MeOH (99:1, 98:2, 95:5, 93:7,
90:10, 85:15, 80:20, and 100:0, each 300 mL) to give Fr. B1–B4. Fr.
B-2 was further fractionated on an RP-18 column and eluted with
MeOH-H2O (MeOH:H2O = 75:25, 7 mL/min, 210 nm) to afford
compounds 1 (28.0 mg, tR = 51.1 min) and 5 (18.0 mg, tR = 32.7 min).
Fraction C (31.7 g) was fractionated using silica gel column
chromatography (CC) with a gradient elution of CHCl2, CHCl2–
MeOH (99:1, 98:2, 95:5, 93:7, 90:10, 85:15, 80:20, and 100:0, each
1.2 L) to yield 6 fractions (Fr.C1–Fr.C6). Fr.C-3 was further purified
via ODS CC and pre-HPLC (MeOH:H2O = 70:30, 7 mL/min, 210 nm)
to give compounds 3 (32.5 mg, tR = 29.2 min) and 9 (43.0 mg,
;
C
3.4.5. Hemslepenside E (5)
White amorphous powder; [a D
]
25: +47.15 (c = 0.1, MeOH); IR
(KBr) nmax 3447, 2975, 2879, 1738, 1692, 1629, 1432, 1371, 1252,
1024 cmꢀ1; 1H data see Table 1; 13C NMR data see Table 2; and ESI-
HRMS m/z 782.4329 ([M + NH4]+) (calcd for C40H60O14 NH4,
782.4327).
3.5. Determination of the glucose configuration in compounds 1–3
and 5
3.5.1. Enzymatic hydrolysis
Compounds 1–3 and 5 (4 mg) were hydrolyzed with cellulase
(Worthington, USA, each 20 mg) in H2O (each 4 mL), and the
mixtures were incubated for 120 h at 40 ꢃC. The reaction mixture
was extracted with EtOAc, and the aqueous layers were evaporated
to dryness to obtain the sugar fractions. The sugar residue and
authentic samples of
dissolved in H2O (each 1 mL) and mixed with EtOH (each 1 mL)
-methylbenzylamine (7 l) and NaBH3CN
D-(+)-glucose and
L-(ꢀ)-glucose were
that contained (S)-(ꢀ)-
a
m
(8 mg), respectively. The mixture was incubated for 4 h at 40 ꢃC.
Glacial acetic acid (0.2 mL) was then added and concentrated to
dryness. Acetic anhydride (0.3 mL) and pyridine (0.3 mL) were
added to the residue and acetylated at room temperature for 24 h.
After the pyridine was removed, the aqueous solution of the
reaction mixture was subjected to a Cleanert C18-N column
(Agela), and H2O, 20% CH3CN and 50% CH3CN (15, 15 and 10 mL)
were used as the eluents.